Prices are updated after-hours

2021 - 02 - 25

Albireo Pharma, Inc.

ALBO | $44.15 -0.23% 0.39% 1.2M

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-100.0% volume)
Earnings Calendar: 2023-02-28
Market Cap: $ 913,961,644
http://www.albireopharma.com
Sec Filling | Patents | 55 employees

(US) Albireo Pharma, Inc. engages in the development and commercialization of bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. It pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA.

gastrointestinal liver liver disease treatment odevixibat

add to watch list Paper trade email alert is off

Allied Healthcare Products, Inc.

AHPI | $0.5501 0

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-66.19% volume)
Earnings Calendar:
Market Cap: $ 2,207,847
http://www.alliedhpi.com
Sec Filling | Patents | 218 employees

Allied Healthcare Products, Inc. manufactures, markets, and distributes a variety of respiratory products used in the health care industry to hospitals, hospital equipment dealers, hospital construction contractors, home health care dealers, and emergency medical product dealers. Its products include respiratory care products, medical gas equipment, and emergency medical products. The company was founded in 1979 and is headquartered in St. Louis, MO.

respiratory construction

add to watch list Paper trade email alert is off

Allscripts Healthcare Solutions, Inc.

MDRX | $8.03 1.01% -5.66% 730K

Technology Services

(0.0% 1d) (2.8% 1m) (-34.7% 1y) (0.0% 2d) (1.0% 3d) (5.7% 7d) (-19.7% volume)
Earnings Calendar: 2023-03-16
Market Cap: $ 877,356,001
http://www.allscripts.com
Sec Filling | Patents | 9600 employees

(US) Allscripts Healthcare Solutions, Inc. engages in the provision of clinical, financial, and operational results services. It operates through the Provider and Veradigm segment. The Provider segment includes the hospitals and health systems, ambulatory, CarePort, FollowMyHealth, EPSiTM, EISClassics, and 2bPrecise strategic business units. The company was founded in 1986 and is headquartered in Chicago, IL.

add to watch list Paper trade email alert is off

America First Multifamily Investors, L.P.

ATAX | $19.1 -2.62%

Finance

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (-0.2% 3d) (0.0% 7d) (71.85% volume)
Earnings Calendar:
Market Cap: $ 424,926,410
http://www.ataxfund.com
Sec Filling | Patents | n/a employees

America First Multifamily Investors LP engages in the acquisition of a portfolio of mortgage revenue bonds that are issued by state and local housing authorities to provide construction and permanent financing for affordable multifamily and student housing and commercial properties. It operates through the following segments: Mortgage Revenue Bond Investments, Multifamily (MF) Properties, Public Housing Capital (PHC) Fund Trusts, and Other Investments. The Mortgage Revenue Bond Investments segment consists of the partnership's portfolio of mortgage revenue bonds which have been issued t provide construction and permanent financing for the residential properties and a commercial property. The MF Properties segment consists of indirect equity interests in multifamily, student housing, and senior citizen residential properties which are not currently financed by mortgage revenue bonds held by partnership but which the partnership eventually intends to finance by such bonds through a restructuring. The Public Housing Capital Fund Trusts segment consists of the assets, liabilities and related income and expenses of the PHC Trusts. The Other Investments segment is comprised of the operations of ATAX Vantage Holdings, LLC, which holds non-controlling equity investments in certain multifamily projects and has issued property notes receivable due from other multifamily projects. The company was founded on April 2, 1998 and is headquartered in Omaha, NE.

acquisitions bone housing construction

add to watch list Paper trade email alert is off

Apollo Endosurgery, Inc.

APEN | $10.0 0.75% 1.7M

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-53.84% volume)
Earnings Calendar: 2023-05-02
Market Cap: $ 579,719,190
http://apolloendo.com
Sec Filling | Patents | 217 employees

Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, OverStitch Sx Endoscopic Suturing System, and Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas; inadvertent perforation of the GI tract; tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon; the treatment of swallowing disorders; esophageal stent fixation and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX.

gastrointestinal endoscopy treatment

add to watch list Paper trade email alert is off

BELLUS Health Inc.

BLU | $14.74 0.03% 0

Health Technology

(0.0% 1d) (0.0% 1m) (1.8% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (688.59% volume)
Earnings Calendar: 2023-08-09
Market Cap: $ 1,869,211,386
http://www.bellushealth.com
Sec Filling | Patents | 40 employees

(CA) BELLUS Health, Inc. is a biopharmaceutical development company which engages in the research and development of novel therapeutics for the treatment of chronic cough and other hypersensitisation disorders. Its product, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

chronic cough hypersensitisation treatment

add to watch list Paper trade email alert is off

Blucora, Inc.

BCOR 4 | $27.19 -0.29% 0.0% 260K

Technology Services

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (NaN% volume)
Earnings Calendar: 2023-02-15
Market Cap: $ 1,309,030,955
http://www.blucora.com
Sec Filling | Patents | 690 employees

(United States) Blucora, Inc. engages in the provision of technology-enabled, tax-smart financial solutions. It operates through the Wealth Management, and Tax Preparation segments. The Wealth Management segment consists of the operations of Avantax, which provides tax-focused wealth management solutions for financial advisors, tax preparers, certified public accounting firms, and its clients. The Tax Preparation segment focuses on digital tax preparation solutions for consumers, small business owners, and tax professionals. The company was founded by Naveen Mahendra Kumar Jain in March 1996 and is headquartered in Irving, TX.

add to watch list Paper trade email alert is off

Borqs Technologies, Inc.

BRQS | $0.43 -41.86% 1.4M

Technology Services

(0.0% 1d) (0.0% 1m) (96.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (1432.47% volume)
Earnings Calendar:
Market Cap: $ 24,588,532
http://www.borqs.com
Sec Filling | Patents | 556 employees

Borqs Technologies, Inc. engages in the provision of android platform solutions, hardware product sales and mobile virtual network operator services. It operates through two segments: Yuantel and Connected Solutions. The Connected Solutions segment develops wireless smart connected devices and cloud solutions. The MVNO serves all the domestic China market, operating under the brand name Yuantel. Borqs Technologies was founded by Pat Sek Yuen Chan & Xiao Bo Li on July 1, 2015 and is headquartered in Beijing, China.

china brands

add to watch list Paper trade email alert is off

Casa Systems, Inc.

CASA | $0.055 -40.91% 65M

Electronic Technology

(0.0% 1d) (-81.8% 1m) (-95.3% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (17290.59% volume)
Earnings Calendar: 2023-11-07
Market Cap: $ 5,450,995
http://www.casa-systems.com
Sec Filling | Patents | 997 employees

(US) Casa Systems, Inc. engages in the provision and development of digital cable video and broadband services. Its products include cable, fixed, mobile, optical, and Wi-Fi networks; and casa access devices. The company was founded by Jerry Guo in 2003 and is headquartered in Andover, MA.

optical c-abl

add to watch list Paper trade email alert is off

Citrix Systems, Inc.

CTXS | $103.9 0.05%

Technology Services

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (130.44% volume)
Earnings Calendar: 2022-11-03
Market Cap: $ 13,183,359,916
http://www.citrix.com
Sec Filling | Patents | 8400 employees

Citrix Systems, Inc. engages in the design, development, and marketing of information technology solutions. It provides digital workspace that unifies apps, data, and services. It markets and licenses its products directly to customers through web, systems integrators, value-added resellers, and service providers. The company was founded by Edward E. Iacobucci on April 17, 1989 and is headquartered in Fort Lauderdale, FL.

information technology

add to watch list Paper trade email alert is off

Clovis Oncology, Inc.

CLVS | $0.0812 -3.94%

Health Technology

(0.0% 1d) (0.0% 1m) (0.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (26.22% volume)
Earnings Calendar: 2023-02-22
Market Cap: $ 11,770,367
http://www.clovisoncology.com
Sec Filling | Patents | 484 employees

Clovis Oncology, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of cancer treatments. Its marketed product Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase (PARP), is offered for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer; and also for the treatment of adult patients with a deleterious BRCA mutation (germline and/or somatic)-associated metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor-directed therapy and a taxane-based chemotherapy. The company was founded by Andrew R. Allen, Gillian C. Ivers-Read, Patrick J. Mahaffy, and Erle T. Mast on April 20, 2009 and is headquartered in Boulder, CO.

acquisitions cancer prostate cancer liver treatment cancer treatments

Drugs

Rubraca (rucaparib)

add to watch list Paper trade email alert is off

Focus Financial Partners Inc.

FOCS | $52.99 -0.02% -0.04% 6.8M

Finance

(0.0% 1d) (0.0% 1m) (2.1% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (-17.3% volume)
Earnings Calendar: 2023-11-02
Market Cap: $ 3,498,318,407
http://www.focusfinancialpartners.com
Sec Filling | Patents | 3400 employees

(US) Focus Financial Partners, Inc. is a holding company, which engages in the provision of wealth management services. It also offers practices, resources, and continuity planning for its partner firms who serve individuals, families, employers, and institutions with comprehensive wealth management services. The company was founded by Leonard R. Chang, Ruediger Adolf and Rajini Sundar Kodialam on July 29, 2015 and is headquartered in New York, NY.

add to watch list Paper trade email alert is off

Genmab A/S

GMAB | News | $28.47 -0.32% -0.32% 430K

Health Technology

(0.0% 1d) (-7.7% 1m) (-30.3% 1y) (0.0% 2d) (-0.3% 3d) (-0.7% 7d) (-18.55% volume)
Earnings Calendar:
Market Cap: $ 18,825,207,851
http://www.genmab.com
Sec Filling | Patents | 548 employees

Genmab A/S operates as an international biotechnology company. The firm develops human antibody therapeutics for the treatment of cancer and other diseases. Its product pipeline include daratumumab, marketed as DARZALEX for the treatment of certain indications of multiple myeloma; teprotumumab-trbw marketed as TEPEZZA for the treatment of thyroid eye disease; and ofatumumab, marketed as Arzerra for the treatment of certain indications of chronic lymphocytic leukemia. The company was founded by Donald Lee Drakeman, Florian Schonharting, and Jan G. J. van de Winkel in 1999 and is headquartered in Copenhagen, Denmark.

eye diseases cancer eye antibody leukemia treatment

add to watch list Paper trade email alert is off

Gilead Sciences, Inc.

GILD | $67.08 0.08% 0.06% 6.2M

Health Technology

(0.0% 1d) (-7.4% 1m) (-19.9% 1y) (0.0% 2d) (0.1% 3d) (0.5% 7d) (-100.0% volume)
Earnings Calendar: 2023-11-07
Market Cap: $ 83,519,779,851
http://www.gilead.com
Sec Filling | Patents | 11800 employees

(US) Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firms primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster, CA.

respiratory liver urea antiviral brands liver disease respiratory diseases

Drugs

Biktarvy (bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate)
Cayston (aztreonam)
COMPLERA (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate)
DESCOVY (emtricitabine and tenofovir alafenamide)
Emtriva (EMTRICITABINE)
Epclusa (Velpatasvir and Sofosbuvir)
Genvoya (elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide)
Hepsera (adefovir dipivoxil)
ODEFSEY (emtricitabine, rilpivirine hydrochloride, and tenofovir alafenamide)
Ranexa (RANOLAZINE)
Sovaldi (SOFOSBUVIR)
Stribild (elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate)
Tybost (COBICISTAT)
Veklury (REMDESIVIR)
VEMLIDY (tenofovir alafenamide)
Viread (TENOFOVIR DISOPROXIL FUMARATE)
Vosevi (SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR)
Zydelig (idelalisib)

add to watch list Paper trade email alert is off

Golar LNG Limited

GLNG | $25.18 -1.41% -1.45% 750K

Transportation

(0.0% 1d) (7.1% 1m) (22.7% 1y) (0.0% 2d) (-1.4% 3d) (0.0% 7d) (53.09% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 2,632,994,466
http://www.golarlng.com
Sec Filling | Patents | 1703 employees

(BM) Golar LNG Ltd. owns and operates liquefied natural gas carriers, floating storage, and regasification unit. It operates through the following segments: Vessel Operations, FLNG, and Power. The Vessel Operations segment operates and charter out vessels on fixed terms to customers. The FLNG segment provides integrated upstream and midstream solution for the development of gas reserves to LNG. The Power segment integrated LNG based downstream solutions, through the ownership and operation of FSRUs and associated terminal and power generation infrastructure. The company was founded on May 10, 2001 and is headquartered in Hamilton, Bermuda.

solar natural gas

add to watch list Paper trade email alert is off

GoPro, Inc.

GPRO | $1.77 -1.12% -1.7% 1.4M

Consumer Durables

(0.0% 1d) (-19.9% 1m) (-58.3% 1y) (0.0% 2d) (-1.1% 3d) (4.1% 7d) (-18.7% volume)
Earnings Calendar: 2024-02-07
Market Cap: $ 223,092,074
http://www.gopro.com
Sec Filling | Patents | 926 employees

(US) GoPro, Inc. engages in manufacturing and selling camera and camera accessories. The firm provides mountable and wearable cameras and accessories, which it refers to as capture devices. Its product brands include HERO9 Black, HERO8 Black, Max, HERO7 Black, HERO7 Silver, GoPro Plus, and GoPro App. The company was founded by Nicholas Woodman in 2002 and is headquartered in San Mateo, CA.

brands

add to watch list Paper trade email alert is off

Gossamer Bio, Inc.

GOSS 4 | $0.7083 -3.97% -4.46% 800K

Health Technology

(0.0% 1d) (-42.3% 1m) (-39.1% 1y) (0.0% 2d) (-4.1% 3d) (-9.0% 7d) (-33.94% volume)
Earnings Calendar: 2024-03-22
Market Cap: $ 159,779,908
http://www.gossamerbio.com
Sec Filling | Patents | 171 employees

(US) Gossamer Bio, Inc. engages in discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its primary product candidate, GB001, is intended for the treatment of moderate-to-severe eosinophilic asthma and other allergic conditions. The company was founded by Faheem Hasnain and Sheila Gujrathi on October 25, 2015 and is headquartered in San Diego, CA.

urea immunology treatment

add to watch list Paper trade email alert is off

Green Plains, Inc.

GPRE 4 | $21.75 -2.34% -2.46% 590K

Process Industries

(0.0% 1d) (0.3% 1m) (-34.0% 1y) (0.0% 2d) (-2.3% 3d) (-2.2% 7d) (-22.66% volume)
Earnings Calendar: 2024-02-07
Market Cap: $ 1,406,016,353
http://www.gpreinc.com
Sec Filling | Patents | 820 employees

Green Plains, Inc. engages in the production of fuel-grade ethanol and corn oil; provision of grain handling; and storage commodity marketing and distribution services. It operates through the following segments: Ethanol Production; Agribusiness and Energy Services; Food and Ingredients; and Partnership. The Ethanol Production segment produces ethanol, distillers grain, and corn oil at ethanol plants in Indiana, Iowa, Minnesota, Nebraska, Tennessee, and Texas. The Agribusiness and Energy Services segment includes grain procurement and its commodity marketing business, which markets, sells, and distributes ethanol, distillers grains, and corn oil produced at ethanol plants. The Food and Ingredients segment is involved in cattle food-grade corn oil operations. The Partnership segment provides fuel storage and transportation services by owning, operating, developing, and acquiring ethanol and fuel storage tanks, terminals, transportation assets, and other related assets and businesses. The company was founded in June 2004 and is headquartered in Omaha, NE.

energy food

add to watch list Paper trade email alert is off

Groupon, Inc.

GRPN 4 | $10.6 0.57% 0.57% 1M

Commercial Services

(0.0% 1d) (-17.9% 1m) (187.3% 1y) (0.0% 2d) (0.6% 3d) (11.5% 7d) (-39.37% volume)
Earnings Calendar: 2024-03-15
Market Cap: $ 413,085,392
http://www.groupon.com
Sec Filling | Patents | 6345 employees

(US) Groupon, Inc. operates as a global scaled two-sided marketplace that connects consumers to merchants. The firm provides marketing services by selling vouchers through online local marketplaces. It operates through North America and International segment. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell on January 15, 2008 and is headquartered in Chicago, IL.

msa

add to watch list Paper trade email alert is off

Guardant Health, Inc.

GH | News 4 | $18.1 4.38% 4.2% 1.8M

Health Services

(0.0% 1d) (2.3% 1m) (-13.6% 1y) (0.0% 2d) (4.4% 3d) (12.6% 7d) (0.53% volume)
Earnings Calendar: 2024-02-22
Market Cap: $ 2,203,000,304
http://www.guardanthealth.com
Sec Filling | Patents | 622 employees

Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA.

cancer treatment

add to watch list Paper trade email alert is off